awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49850238-D837B4E4-D4B5-4F97-8B73-ACA81452811C
Q49850238-D837B4E4-D4B5-4F97-8B73-ACA81452811C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49850238-D837B4E4-D4B5-4F97-8B73-ACA81452811C
Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective.
P2860
Q49850238-D837B4E4-D4B5-4F97-8B73-ACA81452811C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49850238-D837B4E4-D4B5-4F97-8B73-ACA81452811C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cdac13bd499507caadf10f8f3f20f84657edf623
P2860
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.